Alan B. Lancz & Associates’s Qiagen QGEN Stock Holding History

Alan B. Lancz & Associates’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,641	Closed	-$129K	–	175
2023 Q1	$129K	Hold	2,641	–	–	0.13%	169
2022 Q4	$142K	Buy	+2,641	New	+$130K	0.14%	174
2022 Q3	–	Sell	-2,641	Closed	-$139K	–	179
2022 Q2	$139K	Buy	+2,641	New	+$129K	0.14%	166

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Alan B. Lancz & Associates's QGEN Position: Q2 2023 in Review

Alan B. Lancz & Associates sold out of Qiagen (QGEN) in Q2 2023, closing a stake of 2,641 shares — an estimated $129K sold.

Alan B. Lancz & Associates first reported a position in QGEN in Q2 2022 and held it in 3 quarters. The position peaked at $142K in Q4 2022. 282 funds tracked by Wall St. Rank hold QGEN as of Q2 2023.

Alan B. Lancz & Associates reported no remaining Qiagen position as of Q2 2023 after selling out during the quarter.
Alan B. Lancz & Associates sold 2,641 Qiagen shares in Q2 2023, an estimated $129K.
Alan B. Lancz & Associates first reported a position in Qiagen in Q2 2022 and held it in 3 quarters.
Alan B. Lancz & Associates's Qiagen position peaked at $142K in Q4 2022.
282 funds tracked by Wall St. Rank held Qiagen as of Q2 2023.

Based on Alan B. Lancz & Associates's 13F filing for Q2 2023, filed 9 Aug 2023.